Kohmann Bosshard Financial Services LLC Makes New Investment in Danaher Co. (NYSE:DHR)

Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Danaher Co. (NYSE:DHR) during the 4th quarter, Holdings Channel.com reports. The fund purchased 718 shares of the conglomerate’s stock, valued at approximately $165,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Heck Capital Advisors LLC bought a new position in Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. bought a new position in Danaher in the fourth quarter valued at about $31,000. Golden State Wealth Management LLC acquired a new stake in Danaher in the fourth quarter worth about $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher during the 4th quarter worth about $31,000. Finally, Pineridge Advisors LLC raised its stake in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Trading Up 1.0 %

NYSE DHR opened at $207.73 on Monday. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The stock’s 50 day moving average price is $224.58 and its two-hundred day moving average price is $244.76. The stock has a market capitalization of $148.47 billion, a price-to-earnings ratio of 39.34, a PEG ratio of 2.66 and a beta of 0.83.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same period last year, the firm earned $2.09 EPS. As a group, analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. This is an increase from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. Danaher’s dividend payout ratio is currently 24.24%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the stock. Jefferies Financial Group reduced their price objective on shares of Danaher from $285.00 to $260.00 and set a “buy” rating on the stock in a research note on Wednesday, January 29th. Guggenheim started coverage on Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price for the company. The Goldman Sachs Group set a $250.00 price target on Danaher in a research note on Wednesday, January 15th. Raymond James reissued a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Finally, Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research note on Friday, December 13th. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.